Botanix Pharmaceuticals Limited

BXPHF · OTC
Analyze with AI
6/30/2025
6/30/2024
6/30/2023
6/30/2022
Operating Activities
Net Income$0-$14-$9-$13
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0-$2-$0
Stock-Based Comp.$0$0$2$0
Change in WC-$31-$1-$5$2
Other Non-Cash-$48$6$2$0
Operating Cash Flow-$79-$8-$12-$11
Investing Activities
PP&E Inv.-$0-$0-$7-$3
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.-$1-$18$0$0
Investing Cash Flow-$1-$18-$7-$3
Financing Activities
Debt Repay.$28$0-$0-$0
Stock Issued$40$101$22$0
Stock Repurch.-$3-$6$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$0$0$0$0
Financing Cash Flow$65$95$22-$0
Forex Effect-$0$0$0-$0
Net Chg. in Cash-$14$69$3-$14
Supplemental Information
Beg. Cash$79$10$7$22
End Cash$65$79$10$7
Free Cash Flow-$80-$26-$19-$14
Botanix Pharmaceuticals Limited (BXPHF) Financial Statements & Key Stats | AlphaPilot